ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 3 filers reported holding ALBIREO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 330,407 | $5,409,000 | 2.53% |
Perceptive Advisors | 1,960,139 | $31,931,000 | 0.83% |
Birchview Capital, LP | 48,000 | $786,000 | 0.70% |
Chicago Capital, LLC | 492,878 | $8,068,000 | 0.65% |
Artal Group S.A. | 588,125 | $9,628,000 | 0.41% |
PA Capital LLC | 23,198 | $380,000 | 0.34% |
Eversept Partners, LP | 78,029 | $1,277,335 | 0.32% |
HEARTLAND ADVISORS INC | 150,000 | $2,456,000 | 0.26% |
ArrowMark Colorado Holdings LLC | 972,372 | $15,918,000 | 0.21% |
KETTLE HILL CAPITAL MANAGEMENT, LLC | 25,268 | $414,000 | 0.14% |